Oxytocic Pharmaceuticals Market, By Indication (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Hemorrhage, Labor Induction, Labor Arrest), By Route of Administration (Intramuscular, Intravenous Injection/Infusion), By Source of Origin (Synthetic Oxytocin, Natural Oxytocin (Animal Pituitary Extract)), By End User (Hospitals, Maternity Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the Global Oxytocic Pharmaceuticals market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global Oxytocic Pharmaceuticals market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer Inc., Ferring B.V., Novartis AG, and Teva Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global Oxytocic Pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Oxytocic Pharmaceuticals market
Detailed Segmentation:
- Global Oxytocic Pharmaceuticals Market, By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- Global Oxytocic Pharmaceuticals Market, By Route of Administration:
- Intramuscular
- Intravenous Injection/Infusion
- Global Oxytocic Pharmaceuticals Market, By Source of Origin:
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- Global Oxytocic Pharmaceuticals Market, By End User:
- Hospitals
- Maternity Clinics
- Global Oxytocic Pharmaceuticals Market, By Region:
- North America
- By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- By Route of Administration
- Intramuscular
- Intravenous Injection/Infusion
- By Source of Origin
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- By End User
- Hospitals
- Maternity Clinics
- By Country:
- U.S.
- Canada
- Latin America
- By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- By Route of Administration
- Intramuscular
- Intravenous Injection/Infusion
- By Source of Origin
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- By End User
- Hospitals
- Maternity Clinics
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- By Route of Administration
- Intramuscular
- Intravenous Injection/Infusion
- By Source of Origin
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- By End User
- Hospitals
- Maternity Clinics
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- By Route of Administration
- Intramuscular
- Intravenous Injection/Infusion
- By Source of Origin
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- By End User
- Hospitals
- Maternity Clinics
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- By Route of Administration
- Intramuscular
- Intravenous Injection/Infusion
- By Source of Origin
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- By End User
- Hospitals
- Maternity Clinics
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- By Route of Administration
- Intramuscular
- Intravenous Injection/Infusion
- By Source of Origin
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- By End User
- Hospitals
- Maternity Clinics
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Fresenius Kabi AG *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biofutura SpA
- Baxter Healthcare Corporation
- Pfizer Inc.
- Ferring B.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- Regulatory Scenario
- PEST Analysis
- Mergers and Acquisitions
- 4. Global Oxytocic Pharmaceuticals Market, By Indication, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- 5. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- 6. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Synthetic Oxytocin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- 7. Global Oxytocic Pharmaceuticals Market, By End User, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Maternity Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- 8. Global Oxytocic Pharmaceuticals Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- South Africa
- Central Africa
- North Africa
- 9. Competitive Landscape
- Company Profiles
- Fresenius Kabi AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biofutura SpA
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter Healthcare Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ferring B.V.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 22 market data tables and 16 figures on “Global Oxytocic Pharmaceuticals Market - Global forecast to 2027”.